Carbonic anhydrase inhibitors clear tau build-up in zebrafish models of tauopathies

A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is implicated in Alzheimer’s disease.

Neurocrine culls Phase 2 neuropsych med after failing to validate earlier data

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 14, 2024

AI-Powered Dentistry: Modernizing Dental Practices for Better Care

Dr. Cindy Roark, SVP and Chief Clinical Officer at Sage Dental In modern dentistry, the introduction of artificial intelligence (AI) has created a profound shift,

May 21, 2024

Leveraging Personal Health Nurses to Connect the Dots Across the Care Continuum

Mary Bacaj, President, of Value-Based Care, Conifer Health Solutions Our nation is getting sicker. Research by the Employee Benefit Research Institute found that the number

July 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.